Please login to the form below
Medicines Discovery Catapult
This page shows the latest Medicines Discovery Catapult news and features for those working in and with pharma, biotech and healthcare.
LifeArc takes $30m equity stake in Kymab, gains access to antibody tech
Cambridge, UK-based Kymab is focused on developing antibody-based therapeutics, and has built a series of unique drug discovery platforms. ... This is just one of LifeArc’s collaborative efforts, with the charity most recently teaming up with Medicines
Latest news
-
Research charity LifeArc cashes $1.2bn royalty from Keytruda
In March it formed a cancer immunotherapy alliance with CRUK and Ono Pharma, in April it licensed an ion channel drug discovery programme to Daiichi Sankyo, and in early May it ... launched a biomarker and proteomics alliance with the Medicines Discovery
-
Medicines Discovery Catapult to collaborate with LifeArc on new biomarkers
The UK government funded Medicines Discovery Catapult exists to help foster next generation technology in biopharma R&D, and has expertise in the discovery and validation of new biomarker approaches. ... In addition, the charity will fund a two-year
-
AZ and Medicines Catapult collaborate on innovative sound tech in drug discovery
Image: AMI-MS technology in operation. This hi-tech approach is what AstraZeneca and the Medicines Discovery Catapult are hoping to build on with the new collaboration. ... Meanwhile, Medicines Discovery Catapult is upping the ante with its drug
-
Innovate UK supports AI drug discovery project worth £1m
Innovate UK's funding will facilitate the Medicines Discovery Catapult's collaboration with software solutions company Optibrum and University of Cambridge spin-out Intellegens. ... this. Professor John Overington, chief informatics officer of the
More from news
Approximately 2 fully matching, plus 3 partially matching documents found.
Latest appointments
-
Marinomed appoints CFO, Robin Brown is named chair of Medicines Discovery Catapult and more
Medicines Discovery Catapult appoints new chair. Robin Brown has been named chair of Medicines Discovery Catapult, a not-for-profit technology and innovation centre established by Innovate UK. ... Ian Campbell, Interim executive chairman of Innovate UK,
-
Medicines Discovery Catapult appoints CEO
The Alderley Park, Cheshire-based Medicines Discovery Catapult (MDC) has appointed Chris Molloy as its first ever chief executive officer. ... GlaxoKlineSmith. Molloy said: “I am very much looking forward to building and leading the team at the
More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- COVID-19 could be key in identifying viruses with pandemic potential
- Novo Nordisk Foundation commits €127m for new cell therapy facility
- Alzheimer’s Research UK launches ‘Change The Ending’ campaign
- AstraZeneca and Daiichi Sankyo share positive results from phase 3 breast cancer study
- ICR and Merck renew strategic alliance for development of new cancer drugs
- DeepMind’s AI tool classifies effects of mutations in genetic diseases
No results were found
PMHub
AMICULUM
AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >300 healthcare communications professionals,...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
